Table 2.
Characteristics of technologies in the studies.
| Characteristics | Studies (n=126), n (%) | Reference | |||
| Technology typea | |||||
|
|
Telemedicine | 107 (84.9) | [13-119] | ||
|
|
Clinical decision support tools | 11 (8.7) | [78,80-83,88,89,117,120-122] | ||
|
|
Robotic systems | 6 (4.8) | [123-128] | ||
|
|
Symptom trackers | 6 (4.8) | [78,122,129-132] | ||
|
|
Dashboards | 5 (4.0) | [78,93,117,133,134] | ||
|
|
Electronic health records | 4 (3.2) | [44,117,132,135] | ||
|
|
Patient portals | 3 (2.4) | [76,83,117] | ||
|
|
Educational platforms | 2 (1.6) | [136,137] | ||
|
|
Triage tools | 1 (0.8) | [93] | ||
|
|
Reporting system | 1 (0.8) | [83] | ||
|
|
Low-dose computed tomography | 1 (0.8) | [138] | ||
| Mode of telemedicineb | |||||
|
|
Synchronous | 83 (76.9) | [13-22,25,26,28,30,31,33,34,36-45,47,49-51,54-59,62-64,66-76,78,79,82-89,92,93,96,97, 99-103,105,107-116,118,119] | ||
|
|
Asynchronous | 8 (7.4) | [23,24,48,81,91,94,98,129] | ||
|
|
Both | 17 (15.7) | [27,29,32,35,46,52,53,60,61,65,77,80,90,95,104,106,117] | ||
| Technology aima | |||||
|
|
Consultation | 75 (59.5) | [13-87] | ||
|
|
Follow up | 45 (35.7) | [50-81,90,95-102,106,107,116,138] | ||
|
|
Monitoring health status | 22 (17.4) | [78,85-87,93,94,103-108,117,122,126-132,134] | ||
|
|
Education | 14 (11.1) | [46,47,49-52,77,91-94,107,136,137] | ||
|
|
Triage | 12 (9.5) | [52,78,79,82-84,87-90,93,117] | ||
|
|
Treatment | 12 (9.5) | [47,79,85,86,110-116,125] | ||
|
|
Diagnosing | 8 (6.3) | [45-47,89,117,126-128] | ||
|
|
Screening | 4 (3.2) | [80,81,109,124] | ||
|
|
Accessing patient records | 4 (3.2) | [44,117,132,135] | ||
|
|
Monitoring health services | 4 (3.2) | [93,117,133,134] | ||
|
|
Decision making | 3 (2.4) | [117,120,122] | ||
|
|
Generating reports | 3 (2.4) | [78,83,117] | ||
|
|
Clinical assessment | 2 (1.6) | [92,119] | ||
|
|
Administrative support | 2 (1.6) | [118,119] | ||
|
|
Medical data exchange | 2 (1.6) | [83,117] | ||
|
|
Connecting patients and families | 2 (1.6) | [93,108] | ||
|
|
Booking appointments | 2 (1.6) | [78,117] | ||
|
|
Drug delivery | 1 (0.8) | [48] | ||
|
|
Prognosis | 1 (0.8) | [121] | ||
|
|
Personal assistant | 1 (0.8) | [123] | ||
| Technology developmenta,c | |||||
|
|
Built for purpose | 46 (58.2) | [20,25,29,34,41,44,45,47,49,51,56,58,61,69,70,73,76,80,81,83,86,89-91,93-95,101,104-107,114, 115,119,120,122,123,125-128,131,132,135,136] | ||
|
|
Purpose-shifted | 45 (57.0) | [14-16,18,20,23-26,31,34,37-39,47,50,53,54,57,62-64,67,69-72,74-77,87,90,96,97,100,101,107, 108,111,113,115,117,120,137] | ||
| Social media and videoconferencing platformsa | |||||
|
|
Zoom | 22 (17.5) | [16,25,31,34,37,50,57,62,67,69,70,72,74-77,87,108,111,113,115,137] | ||
|
|
12 (9.5) | [23-25,38,53,54,57,62,63,90,100,120] | |||
|
|
FaceTime | 6 (4.8) | [20,72,76,97,101,108] | ||
|
|
5 (4.0) | [14,15,71,96,107] | |||
|
|
WebEx | 5 (4.0) | [47,64,108,111,115] | ||
|
|
Google Duo | 5 (4.0) | [20,25,62,76,101] | ||
|
|
Skype | 4 (3.2) | [26,62,76,100] | ||
|
|
Telegram | 3 (2.4) | [25,62,90] | ||
|
|
Messenger | 2 (1.6) | [25,90] | ||
| Target users | |||||
|
|
Health consumers and health care professionals | 103 (81.7) | [13-32,34-41,43,45-60,62-84,86-93,95-102,104-118,123,131,132,138] | ||
|
|
Health care professionals | 15 (11.9) | [33,42,44,59,85,103,119,121,125-128,135-137] | ||
|
|
Health consumers | 5 (4.0) | [61,94,124,129,130] | ||
|
|
Decision makers | 3 (2.4) | [122,133,134] | ||
| Target conditionsa | |||||
|
|
COVID-19 | 38 (30.2) | [26,29,44,45,52,75,78,81,85,88,89,93-95,103,104,106-109,117-119,121,122,124,126-136,138] | ||
|
|
Any conditions | 21 (16.7) | [15,18,25,28,35,40,48,49,54,55,73,79,80,83,84,90,100,102,105,123,137] | ||
|
|
Mental conditions | 13 (10.3) | [31,33,42,50,74,76,87,91,111-115] | ||
|
|
Cardiovascular conditions | 9 (7.1) | [14,61,65,68,86,96,97,120,125] | ||
|
|
Cancer conditions | 6 (4.8) | [16,32,46,66,77,82] | ||
|
|
Neurological conditions | 6 (4.8) | [20,23,30,58,62,101] | ||
|
|
Prenatal and postnatal conditions | 6 (4.8) | [41,47,56,59,60,110] | ||
|
|
Diabetes | 5 (4.0) | [13,17,21,37,99] | ||
|
|
Orthodontic conditions | 4 (3.2) | [39,43,69,70] | ||
|
|
Rheumatic conditions | 4 (3.2) | [22,27,38,63] | ||
|
|
Ophthalmic conditions | 3 (2.4) | [24,53,71] | ||
|
|
Urologic conditions | 3 (2.4) | [72,92,134] | ||
|
|
Dermatological conditions | 3 (2.4) | [19,57,64] | ||
|
|
Ear, nose, and throat conditions | 2 (1.6) | [67,116] | ||
|
|
Liver conditions | 2 (1.6) | [36,98] | ||
|
|
Gastrointestinal conditions | 1 (0.8) | [36,91] | ||
|
|
Orthodontic conditions | 1 (0.8) | [34] | ||
|
|
Reproductive conditions | 1 (0.8) | [87] | ||
|
|
Transplant conditions | 1 (0.8) | [51] | ||
| Settinga |
|
|
|||
|
|
Hospitals | 81 (64.3) | [13-15,17,18,21-23,27-35,37,41-44,48,50-60,64,66,69-73,77,79,80,82,85,88-90,92-94,96-100, 102-108,110,116-123,126-128,133-135,137,138] | ||
|
|
Medical clinics | 46 (36.5) | [16,19,20,24-26,36,38-41,45-47,49,52,57,61-63,65,67,68,74-76,83,84,86-88,93,95,101,109,111-115, 117,123,125,131,132] | ||
|
|
Community | 7 (5.6) | [78,91,123,124,129,130,136] | ||
| Internet connectivitya |
|
|
|||
|
|
Web-based | 106 (84.1) | [13-16,18-20,23-32,34-39,41,43-54,56-58,60-65,67,69-81,83-90,92-98,100-115,117,119,120,122, 125-133,135-137] | ||
|
|
Non–web-based | 63 (50) | [13,17,20-24,26-33,35,40,42,43,46,49,52,53,55,59-62,65-68,74,76,77,79,81,82,84,88-93,95,97,99,101, 102,104,106,112,115-118,120,121,123,124,134,138] | ||
| Modesa |
|
|
|||
|
|
Mobile apps | 86 (68.3) | [13-16,18-20,23-26,28,30-32,34,36-39,41,43-45,47,49,50,53,54,56,57,61-65,67,69-78,80,81,84-88,90, 92-94,96-98,100-115,117,120,122,129-132,135,137] | ||
|
|
Desktop apps | 73 (57.9) | [14,16,19,20,23-26,28-32,34-38,47,50,52-54,57,58,62-65,67,69-78,80,82,83,85,87-90,92,93,96,100, 101,105,107-111,113-115,119-121,131,133,134,137,138] | ||
|
|
Telephone calls | 49 (38.9) | [13,17,20-24,27-33,35,40,42,43,46,49,52,53,55,59-62,65-68,76,77,79,82,84,90,92,97,99,101, 102,104,106,112,115-118] | ||
|
|
Websites | 45 (35.7) | [14-16,20,23-26,31,34,37,38,46,47,50,51,53,57,62-64,67,69-72,74-77,83,87,90,95,96,100,101,107, 108,111,113,115,120,136,137] | ||
|
|
Emails | 13 (10.3) | [27,29,32,35,46,53,57,60,65,77,90,95,117] | ||
|
|
Robot | 6 (4.8) | [123-128] | ||
|
|
Text messages | 2 (1.6) | [48,91] | ||
|
|
Interphone | 1 (0.8) | [26] | ||
|
|
Automated vital-sign monitor | 1 (0.8) | [93] | ||
|
|
Closed-circuit television cameras | 1 (0.8) | [103] | ||
|
|
Headset | 1 (0.8) | [119] | ||
aNumbers do not add to total.
bNumber of telemedicine studies (n=108) was used to calculate percentages.
cWe were able to identify the type of technology development in 79 studies; therefore, we used this number to calculate percentages.